Get to knowAbout Us
OMass is an Oxford University spin-out company applying MS
technology to drug discovery.
The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulation of complex formation, with both effects, binding and function, being measured by a change in mass.
These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors.
OMass is backed by Syncona Ltd and Oxford Sciences Innovation.